Pathogenesis and Current Treatment of Osteosarcoma: Perspectives for Future Therapies

Osteosarcoma is the most common primary malignant bone tumor in children and young adults. The standard-of-care curative treatment for osteosarcoma utilizes doxorubicin, cisplatin, and high-dose methotrexate, a standard that has not changed in more than 40 years. The development of patient-specific...

Descripción completa

Detalles Bibliográficos
Autores principales: Rathore, Richa, Van Tine, Brian A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8000603/
https://www.ncbi.nlm.nih.gov/pubmed/33809018
http://dx.doi.org/10.3390/jcm10061182

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8000603/
https://www.ncbi.nlm.nih.gov/pubmed/33809018
http://dx.doi.org/10.3390/jcm10061182

Ejemplares similares